DNA11 Argenx 999-2-MG-2000 Platform Study ISA Protocol

Clinical Trial Grant

Duke Scholars

Principal Investigator Vern Charles Juel Neurology, Neuromuscular Disease

Awarded By

Argenx BV

Start Date

June 16, 2026

End Date

July 7, 2036

Awarded By

Argenx BV

Start Date

June 16, 2026

End Date

July 7, 2036